EEWOWW is an online personal knowledge management tool. Click to find out more!
My Publications
Number of Items: 20
Sort by: Last Updated | Year | Type | Title Order: Descending
Clear results
 
Save item(s) into EEWOWW Export to RIS, BibTeX, APA, Chicago, etc.
1.

A prospective study comparing whole-body skeletal X-ray survey with 18F-FDG-PET/CT, 18F-NaF-PET/CT and whole-body MRI in the detection of bone lesions in multiple myeloma patients.

Acta radiologica open , Volume 6 , Issue 10 (2017)
Eva Dyrberg , Helle W Hendel , Gina Al-Farra , Lone Balding , Vibeke B Løgager , Claus Madsen , Henrik S Thomsen
2.

Role of Osteocytes in Myeloma Bone Disease: Anti-sclerostin Antibody as New Therapeutic Strategy.

Frontiers in immunology , Volume 9 (2018)
Denise Toscani , Marina Bolzoni , Marzia Ferretti , Carla Palumbo , Nicola Giuliani
3.

Pathogenesis of bone disease in multiple myeloma: from bench to bedside.

Blood cancer journal , Volume 8 , Issue 1 (2018)
Evangelos Terpos , Ioannis Ntanasis-Stathopoulos , Maria Gavriatopoulou , Meletios A Dimopoulos
4.

Bone-targeted agents in multiple myeloma.

Hematology reports , Volume 10 , Issue 1 (2018)
Hiroko Nishida
5.

Pathogenesis beyond the cancer clone(s) in multiple myeloma.

Blood , Volume 125 , Issue 20 (2015)
Giada Bianchi , Nikhil C Munshi
6.

Pathophysiology of myeloma bone disease.

Best practice & research. Clinical haematology , Volume 20 , Issue 4 (2007)
Flavia R Esteve , G David Roodman
7.

Autologous stem cell transplantation normalizes abnormal bone remodeling and sRANKL|[sol]|osteoprotegerin ratio in patients with multiple myeloma

Leukemia , Volume 18 , Issue 8 (2004)
E Terpos , M Politou , R Szydlo , E Nadal , S Avery
8.

The proteasome inhibitor bortezomib affects osteoblast differentiation in vitro and in vivo in multiple myeloma patients.

Blood , Volume 110 , Issue 1 (2007)
Nicola Giuliani , Francesca Morandi , Sara Tagliaferri , Mirca Lazzaretti , Sabrina Bonomini , Monica Crugnola , Cristina Mancini , Eugenia Martella , Luca Ferrari , Antonio Tabilio , Vittorio Rizzoli
9.

Bortezomib inhibits human osteoclastogenesis.

Leukemia , Volume 21 , Issue 9 (2007)
I von Metzler , H Krebbel , M Hecht , R A Manz , C Fleissner , M Mieth , M Kaiser , C Jakob , J Sterz , L Kleeberg , U Heider , O Sezer
10.

Pulse treatment with the proteasome inhibitor bortezomib inhibits osteoclast resorptive activity in clinically relevant conditions.

Leukemia research , Volume 32 , Issue 11 (2008)
P Boissy , T L Andersen , T Lund , K Kupisiewicz , T Plesner , J M Delaissé